May’s edition of PMLiVE magazine features the piece ‘Good Pharma: Astellas’ Action on Fistula works to build surgical capacity and transform patients’ lives in Kenya’, for International Day to End Obstetric Fistula.
The case study highlights Action on Fistula, the innovative partnership between Astellas Pharma EMEA and Fistula Foundation to transform the lives of women in Kenya living with obstetric fistula.
“Astellas’ investment in Fistula Foundation has done something truly transformational, not just for Kenya but for the field of fistula treatment. More facilities in Kenya now provide routine fistula treatment, more surgeons are delivering this care, and more communities know that this devastating injury exists, and that it can be treated for free,” says Kate Grant, CEO of Fistula Foundation.
Read the full case study on page 16 and 17 at the link below:
Pharmaceutical Market Europe Magazine, healthcare and pharma news, features, jobs and opinions,